Healgen Scientific Spotlights the Rapid Check® COVID-19/Flu A&B Antigen Test to Help Families Stay Prepared for the Respiratory Virus Season

HOUSTON, Nov. 27, 2025 /PRNewswire/ -- As the holiday season approaches, gatherings among family and friends are expected to increase the risk of respiratory virus transmission, including COVID-19 and influenza. In response, Healgen^® Scientific highlights the Rapid Check^® COVID-19/Flu A&B Antigen Test, a 3-in-1 at-home rapid test designed to help users quickly distinguish between COVID-19 and common flu viruses.

According to the U.S. Centers for Disease Control and Prevention (CDC), the upcoming 2025–2026 respiratory disease season is expected to bring a comparable level of hospitalizations for COVID-19, influenza, and RSV as last year's peak. As public gatherings and family travel increase from Thanksgiving through New Year's, the ability to accurately identify the source of symptoms at home has become more essential than ever for preventing family transmission and ensuring timely medical care.

"During peak respiratory seasons, identifying the cause of illness quickly is the first step to taking the right action," said Dr. Bingliang Fang, CEO of Healgen Scientific. "Our combo rapid test addresses a critical gap in clinical diagnostics by providing a reliable and user-friendly solution for individuals to test themselves at home. Early diagnosis enables faster initiation of appropriate treatment, leading to improved health outcomes and reduced disease transmission."

Reliable Results in Minutes: Healgen Rapid Check^® COVID-19/Flu A&B Antigen Test

• 3-in-1 Detection: Simultaneously identifies COVID-19, Influenza A, and Influenza B, enabling users to determine the cause of symptoms with one simple test.
• Fast Results: Provides reliable results within 15 minutes through a dual-window design for easy interpretation.
• Easy Sampling: Uses a shallow anterior nasal swab, suitable for individuals aged 2 and older, ensuring comfort and accessibility for the whole family.
• Exceptional Accuracy: FDA-reviewed data from a clinical study of symptomatic individuals demonstrated the Healgen test correctly identified 99% of negative and 92% of positive SARS-CoV-2 samples, 99.9% of negative Flu A and B samples, and 92.5% and 90.5% of positive Flu A and Flu B samples, respectively. (Source: U.S. FDA Press Release)

The Healgen Rapid Check^® COVID-19/Flu A&B Antigen Test provides consumers with a powerful tool to manage their health with confidence at home, eliminating the uncertainty between common cold, flu, and COVID-like symptoms. With the test's rapid results and professional-grade reliability, families can make timely healthcare decisions during the busiest travel and gathering season of the year.

About Healgen

Founded in 2007 in Houston, Texas, Healgen Scientific is a leading global in-vitro diagnostics (IVD) developer and manufacturer, dedicated to advancing healthcare through innovative and reliable testing technologies. With a portfolio covering infectious disease, toxicology, and molecular diagnostics, Healgen serves healthcare providers and communities worldwide, empowering better clinical decisions and improved health outcomes. For more information, please visit Healgen's official website.

** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **

Healgen Scientific Spotlights the Rapid Check® COVID-19/Flu A&B Antigen Test to Help Families Stay Prepared for the Respiratory Virus Season

Healgen Scientific Spotlights the Rapid Check® COVID-19/Flu A&B Antigen Test to Help Families Stay Prepared for the Respiratory Virus Season

TOKYO, April 2, 2026 /PRNewswire/ -- GA technologies Co., Ltd. (Headquarters: Minato-ku, Tokyo; President, CEO: Ryo Higuchi; Stock Code: 3491; hereinafter referred to as the "Company") announces that its AI real estate investment service, "RENOSY," has launched an initiative to rebrand "Renters Warehouse" (operated by RW OpCo, LLC [Headquarters: United States], a Group company), as "RENOSY by Renters Warehouse."

URL: https://www.renterswarehouse.com/

• Background and Outlook of the Brand Integration and Renewal

Since its founding in 2013, the Company has operated under its corporate philosophy:

"Spark excitement and inspiration by fusing technology with innovation to propel the world forward." The Company's core business is the AI real estate investment service "RENOSY," which leverages technology to provide unique one-stop services for property purchase, management, and sale.

RW OpCo, LLC, founded in 2007, operates the real estate investment marketplace "Renters Warehouse." Primarily serving individuals and institutional investors in the United States, the platform functions as an online marketplace and currently operates in 18 states and 31 locations across the country.

The Company completed the consolidation of RW OpCo, LLC as a subsidiary in March 2024 and began providing real estate services in the U.S. market.^[1] Since the fiscal year ending October 2025, the business has maintained strong performance, achieving quarterly profitability and growing rapidly to become the Company's third pillar of profit.^[2]

The Company has now moved to rebrand its U.S. business from "Renters Warehouse" to "RENOSY by Renters Warehouse," aiming to drive further growth in the U.S. market and maximize group synergies. Through the full-scale expansion of "RENOSY" in the U.S. market, the Company looks to promote the adoption of services that enable reliable, seamless, and optimal asset formation through real estate in the country.

The impact of this matter on the Company's business results is insignificant.

• AI Real Estate Investment RENOSY

RENOSY is an AI real estate investment service that utilizes technology. Reliable, seamless, and optimal asset-building through real estate is realized by providing one-stop support for the purchase, management, and sale of property, maximizing operational effectiveness. An extensive product lineup is offered that includes condominiums, apartments, and detached houses, etc. Surveys conducted by Tokyo Shoko Research have ranked RENOSY No. 1 in Japan in real estate investment sales and purchases.^[3]